Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more inclusive treatment.